1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-06-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 12581195 2023-06-01 2024-05-31 12581195 2024-05-31 12581195 2023-05-31 12581195 2022-06-01 2023-05-31 12581195 2023-05-31 12581195 2022-05-31 12581195 bus:Director1 2023-06-01 2024-05-31 12581195 core:WithinOneYear 2024-05-31 12581195 core:WithinOneYear 2023-05-31 12581195 core:ShareCapital 2024-05-31 12581195 core:ShareCapital 2023-05-31 12581195 core:SharePremium 2024-05-31 12581195 core:SharePremium 2023-05-31 12581195 core:OtherReservesSubtotal 2024-05-31 12581195 core:OtherReservesSubtotal 2023-05-31 12581195 core:RetainedEarningsAccumulatedLosses 2024-05-31 12581195 core:RetainedEarningsAccumulatedLosses 2023-05-31 12581195 bus:SmallEntities 2023-06-01 2024-05-31 12581195 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 12581195 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 12581195 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 12581195 bus:FullAccounts 2023-06-01 2024-05-31
COMPANY REGISTRATION NUMBER: 12581195
Optimi Health Limited
Filleted Unaudited Financial Statements
31 May 2024
Optimi Health Limited
Financial Statements
Year ended 31 May 2024
Contents
Page
Statement of financial position
1
Notes to the financial statements
2
Optimi Health Limited
Statement of Financial Position
31 May 2024
2024
2023
Note
£
£
Current assets
Cash at bank and in hand
47,411
52,558
Creditors: amounts falling due within one year
5
6,607
750
--------
--------
Net current assets
40,804
51,808
--------
--------
Total assets less current liabilities
40,804
51,808
--------
--------
Net assets
40,804
51,808
--------
--------
Capital and reserves
Called up share capital
104
104
Share premium account
84,996
84,996
Other reserves
219,986
129,986
Profit and loss account
( 264,282)
( 163,278)
---------
---------
Shareholders funds
40,804
51,808
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 4 February 2025 , and are signed on behalf of the board by:
Mr P A C Shotter
Director
Company registration number: 12581195
Optimi Health Limited
Notes to the Financial Statements
Year ended 31 May 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 85 First Floor, Great Portland Street, London, W1W 7LT, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The accounts have been prepared on a going concern basis which relies upon the continuing support of the investors.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Government grants
Government grants are recognised using the accrual model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
6,607
750
-------
----